Literature DB >> 32317240

The discriminatory power of bleeding assessment tools in adult patients with a mild to moderate bleeding tendency.

Johanna Gebhart1, Stefanie Hofer2, Alexandra Kaider3, Judit Rejtö2, Cihan Ay2, Ingrid Pabinger2.   

Abstract

BACKGROUND: Bleeding assessment tools (BATs) have been developed to quantify bleeding severity. Their ability to predict for the diagnosis of a bleeding disorder has not been thoroughly investigated.
OBJECTIVES: To evaluate the ability of the Vicenza BAT and the ISTH BAT to distinguish patients with an established bleeding disorder from those with bleeding of unknown cause (BUC). PATIENTS/
METHODS: Three-hundred fifty-nine patients (228 with BUC, 64%) from the Vienna Bleeding Biobank were assessed in this study.
RESULTS: The bleeding scores were similar in patients with an established diagnosis of a bleeding disorder compared to patients with BUC. Both BATs had a low sensitivity and specificity for the diagnosis of a bleeding disorder with areas under the receiver operating characteristic (ROC) curves of 0.53 (95% confidence interval 0.47-0.60) for the Vicenza BAT and 0.52 (0.46-0.59) for the ISTH BAT. In terms of specific diagnoses, both scores were most accurate in diagnosing von Willebrand disease (VWD, areas under the ROC curve; Vicenza BAT 0.67 (0.45-0.90); ISTH BAT 0.70 (0.50-0.90)). A separate evaluation of different bleeding symptoms in patients who had undergone surgery and tooth extraction revealed that postpartum bleeding and bleeding from small wounds was predictive for diagnosing a MBD in multivariable analysis.
CONCLUSIONS: The Vicenza- and the ISTH BAT have a low ability to distinguish patients with an established bleeding disorder from those with BUC.
Copyright © 2020 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bleeding assessment tool; Bleeding of unknown cause; ISTH-BAT; Mild bleeding tendency; Platelet function defect; Von Willebrand disease

Year:  2020        PMID: 32317240     DOI: 10.1016/j.ejim.2020.04.023

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  4 in total

1.  Elevated levels of tissue factor pathway inhibitor in patients with mild to moderate bleeding tendency.

Authors:  Dino Mehic; Alexander Tolios; Stefanie Hofer; Cihan Ay; Helmuth Haslacher; Judit Rejtö; Willem H Ouwehand; Kate Downes; Matthias Haimel; Ingrid Pabinger; Johanna Gebhart
Journal:  Blood Adv       Date:  2021-01-26

2.  Thrombomodulin in patients with mild to moderate bleeding tendency.

Authors:  Dino Mehic; Alexander Tolios; Stefanie Hofer; Cihan Ay; Helmuth Haslacher; Kate Downes; Matthias Haimel; Ingrid Pabinger; Johanna Gebhart
Journal:  Haemophilia       Date:  2021-10-10       Impact factor: 4.263

3.  An Investigation of ABO Blood Type and the Platelet Delta Granule Storage Pool.

Authors:  Ryan J Reagans; Paula M Kramer; Jacob A Cichocki; William T Gunning
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

4.  Association of ABO blood group with bleeding severity in patients with bleeding of unknown cause.

Authors:  Dino Mehic; Stefanie Hofer; Christof Jungbauer; Alexandra Kaider; Helmuth Haslacher; Ernst Eigenbauer; Judit Rejtő; Dieter Schwartz; Bernd Jilma; Cihan Ay; Ingrid Pabinger; Johanna Gebhart
Journal:  Blood Adv       Date:  2020-10-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.